February 2024 in “Buletin Veteriner Udayana” The dog with severe hair loss and itching improved after treatment for ehrlichiosis and demodicosis.
January 2024 in “Jurnal Ilmu Kesehatan Hewan” Oreo the dog got better from skin and worm infections after treatment and cleaner living conditions.
January 2024 in “RSC pharmaceutics” Removing the outer skin layer increases drug absorption and offers non-invasive treatment options, with some methods allowing for quick skin recovery.
December 2023 in “Revista de la Facultad de Ciencias Médicas (Quito)” Fever and rash can be early signs of lupus.
July 2023 in “Journal of Cutaneous and Aesthetic Surgery” Combining platelet-rich plasma with other treatments may improve hair growth in people with hair loss, but more research is needed.
June 2023 in “F1000Research” A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.
April 2023 in “Media Dermato Venereologica Indonesiana” COVID-19 reinfection may trigger alopecia areata.
March 2023 in “Journal of Cosmetic Dermatology” Dilated scalp capillaries might be a sign of hair loss related to COVID-19.
November 2022 in “Medicina” COVID-19 may cause temporary hair loss due to the body's immune response.
Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.
May 2022 in “F1000Research” During the COVID-19 pandemic, Iraqi women experienced more hair loss and certain skin conditions, while contagious skin infections decreased.
May 2022 in “Advances in Cosmetic Surgery” Platelet-rich fibrin helps in healing and rejuvenation but results vary and can take time.
September 2021 in “Authorea (Authorea)” Systemic lupus erythematosus caused severe abdominal issues in a Sudanese woman.
Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.
Stem cell therapy shows promise for better burn healing but needs more research and standardization.
August 2021 in “Journal of skin and stem cell” Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.
May 2021 in “ThinkTech (Texas Tech University)” BlastX helps heal uninfected wounds but doesn't improve healing in infected ones.
December 2020 in “Journal of Pakistan Association of Dermatology” COVID-19 recovery can lead to temporary hair loss called telogen effluvium.
May 2020 in “The Journal of Pediatrics” Tinea capitis can be quickly diagnosed and treated using dermoscopy to prevent hair damage.
July 2019 in “Journal of Aesthetic Nursing” The JCCP's Premises Standards aim to make non-surgical cosmetic treatments safer and higher quality.
Microneedling and PRP are generally safe but can cause mild skin issues; serious problems are rare.
July 2018 in “Journal of The American Academy of Dermatology” Fluorescent tattoos are a good way to mark the scalp for hair treatments because they're accurate, invisible in normal light, and have low risk.
January 2018 in “Figshare” Horizontal sections of scalp biopsies are useful for telling the difference between Androgenetic Alopecia and Alopecia Areata.
December 2017 in “Springer eBooks” Transplant patients often get skin problems, with treatments varying by condition.
June 2013 in “Annals of the rheumatic diseases” Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.
January 2011 in “Journal of Cutaneous and Aesthetic Surgery” The Editor-in-Chief is proud of the journal's growth and improvements during his term and optimistic about its future.
January 2011 in “Medicina interna de México” The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.
Use mild topical steroids to avoid side effects, especially in children.
Oral contraceptives are generally recommended for healthy young girls, but specific types may vary based on individual health conditions and barrier methods are less popular among adolescents.
June 2025 in “British Journal of Dermatology” Tofacitinib was more effective than methotrexate for treating alopecia areata.